Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY, Alsaieedi A, Algaissi A, Almahboub S, Al-Raddadi RM, Shabouni OI, Alhabbab R, Alfaraj AA, Alamri SS, Aljehani ND, Abdulal RH, Alfaleh MA, Abujamel TS, Alkayyal AA, Mahmoud AB, Abuzenadah AM, Hashem AM. Alhabbab RY, et al. Among authors: alkayyal aa. Viruses. 2021 Jul 20;13(7):1413. doi: 10.3390/v13071413. Viruses. 2021. PMID: 34372618 Free PMC article.
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
Alfaleh MA, Alsaab HO, Mahmoud AB, Alkayyal AA, Jones ML, Mahler SM, Hashem AM. Alfaleh MA, et al. Among authors: alkayyal aa. Front Immunol. 2020 Aug 28;11:1986. doi: 10.3389/fimmu.2020.01986. eCollection 2020. Front Immunol. 2020. PMID: 32983137 Free PMC article. Review.
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
Algaissi A, Alfaleh MA, Hala S, Abujamel TS, Alamri SS, Almahboub SA, Alluhaybi KA, Hobani HI, Alsulaiman RM, AlHarbi RH, ElAssouli MA, Alhabbab RY, AlSaieedi AA, Abdulaal WH, Al-Somali AA, Alofi FS, Khogeer AA, Alkayyal AA, Mahmoud AB, Almontashiri NAM, Pain A, Hashem AM. Algaissi A, et al. Among authors: alkayyal aa. Sci Rep. 2020 Oct 6;10(1):16561. doi: 10.1038/s41598-020-73491-5. Sci Rep. 2020. PMID: 33024213 Free PMC article.
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
Hashem AM, Algaissi A, Almahboub SA, Alfaleh MA, Abujamel TS, Alamri SS, Alluhaybi KA, Hobani HI, AlHarbi RH, Alsulaiman RM, ElAssouli MZ, Hala S, Alharbi NK, Alhabbab RY, AlSaieedi AA, Abdulaal WH, Bukhari A, Al-Somali AA, Alofi FS, Khogeer AA, Pain A, Alkayyal AA, Almontashiri NAM, Ahmad BM, Li X. Hashem AM, et al. Among authors: alkayyal aa. Viruses. 2020 Dec 4;12(12):1390. doi: 10.3390/v12121390. Viruses. 2020. PMID: 33291713 Free PMC article.
Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals.
Alhabbab RY, Algaissi A, Mahmoud AB, Alkayyal AA, Al-Amri S, Alfaleh MA, Basabrain M, Alsubki RA, Almarshad IS, Alhudaithi AM, Gafari OAA, Alshamlan YA, Aldossari HM, Alsafi MM, Bukhari A, Bajhmom W, Memish ZA, Al Salem WS, Hashem AM. Alhabbab RY, et al. Among authors: alkayyal aa. Clin Infect Dis. 2023 Feb 8;76(3):e308-e318. doi: 10.1093/cid/ciac456. Clin Infect Dis. 2023. PMID: 35675306 Free PMC article.
Advances in immunotherapy for glioblastoma multiforme.
Mahmoud AB, Ajina R, Aref S, Darwish M, Alsayb M, Taher M, AlSharif SA, Hashem AM, Alkayyal AA. Mahmoud AB, et al. Among authors: alkayyal aa. Front Immunol. 2022 Oct 12;13:944452. doi: 10.3389/fimmu.2022.944452. eCollection 2022. Front Immunol. 2022. PMID: 36311781 Free PMC article. Review.
Construction of VSVΔ51M oncolytic virus expressing human interleukin-12.
Abdulal RH, Malki JS, Ghazal E, Alsaieedi AA, Almahboub SA, Khan MY, Alsulaiman RM, Ghaith MM, Abujamel TS, Ganash M, Mahmoud AB, Alkayyal AA, Hashem AM. Abdulal RH, et al. Among authors: alkayyal aa. Front Mol Biosci. 2023 May 15;10:1190669. doi: 10.3389/fmolb.2023.1190669. eCollection 2023. Front Mol Biosci. 2023. PMID: 37255540 Free PMC article.
Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine.
Alkayyal AA, Darwish M, Ajina R, Alabbas SY, Alotaibi MA, Alsofyani A, Bokhamseen M, Hakami M, Albaradie OA, Moglan AM, Hala S, Alsahafi AF, Zakri S, Almuzaini A, Alsharari K, Kaboha F, Taher MY, Zein HS, Alroqi F, Mahmoud AB. Alkayyal AA, et al. Front Bioeng Biotechnol. 2023 Jul 17;11:1150892. doi: 10.3389/fbioe.2023.1150892. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37528991 Free PMC article.
32 results